Zobrazeno 1 - 10
of 166
pro vyhledávání: '"MAURO GELLER"'
Autor:
Isadora de Carvalho e Silva, Thais Russomano, Ricardo Alves Ferreira, Marli do Carmo Cupertino, Fabíola Alves Alcântara, Mauro Geller, Oswaldo Monteiro Del Cima, Rodrigo Siqueira-Batista
Publikováno v:
Journal of Aerospace Technology and Management, Vol 15 (2023)
The historic flight of cosmonaut Yuri Alekeseyevich Gagarin, in 1961, established the need for research regarding the physiological adaptations of the human body when exposed to the space environment. Since then, several morpho-functional transformat
Externí odkaz:
https://doaj.org/article/c36312a443e94e038d3cc2ec8c886bce
Autor:
Záfia R Gonçalves, Alana B. Kohn, Saulo D. Silva, Barbara A. Louback, Lívia C.M. Velasco, Erika Cesar O. Naliato, Mauro Geller
Publikováno v:
DST, Vol 24, Iss 1 (2023)
Introduction: the human immunodeficiency virus (HIV) epidemic began in the 1980’s. As there were no therapeutic options at that time, diagnosed patients evolved rapidly to death. With the implementation of anti-retroviral therapy in 1996, HIV infec
Externí odkaz:
https://doaj.org/article/a549ce41109b44b5a384ad25df9ef9dd
Autor:
Carlos P. Nunes, MD, Claudio Rodrigues, MD, Mendel Suchmacher, MD, Claudia Regina Esteves, MD, Karin Gonçalves, PhD, Hélio Rzetelna, MD, Rafael V. Rodrigues, MD, Luciana Regina de Vasconcelos, MD, Spyros G.E. Mezitis, MD, PhD, Heros Rabelo, MSc, Renato Kaufmann, MD, PhD, Fernanda Schwarz, MChem, Henrique Goldberg, (In Memoriam), MD, Aline Sintoveter, MD, Mauro Geller, MD, PhD
Publikováno v:
Current Therapeutic Research, Vol 99, Iss , Pp 100719- (2023)
ABSTRACT: Background: Motion sickness (kinetosis) is a common and temporarily incapacitant ailment, manageable with behavioral as well as pharmacological measures. Objective: To assess the effectiveness and safety of a combination of gamma-aminobutyr
Externí odkaz:
https://doaj.org/article/e655c38304934710ae409ffb2d59316b
Autor:
Luiz Guilherme Darrigo Junior, Victor Evangelista de Faria Ferraz, Marina Candido Visontai Cormedi, Luissa Hikari Hayashi Araujo, Mariana Prado Silva Magalhães, Rafaella Curis Carneiro, Luis Henrique Nunes Sales, Mendel Suchmacher, Karin Soares Cunha, Aguinaldo Bonalumi Filho, David Rubem Azulay, Mauro Geller
Publikováno v:
Brain and Behavior, Vol 12, Iss 6, Pp n/a-n/a (2022)
Abstract Background Neurofibromatosis type 1 (NF1) is a chronic and progressive autosomal dominant genetic and sporadic disease characterized by cutaneous and neurological abnormalities. Plexiform neurofibroma (PN), a significant cause of clinical co
Externí odkaz:
https://doaj.org/article/a47b29593a3644b091a7d34950f6e60b
Autor:
Lisa Brauer Oliveira, Mauro Geller, Karin Soares Cunha, Alessandra Santos, Allan Bernacchi, Allan E. Rubenstein, Sanyu Takirambudde, Spyros Mezitis, Carolina de Almeida Ito Brum, Luiz Guilherme Darrigo, Jr., Marcia Gonçalves Ribeiro
Publikováno v:
Heliyon, Vol 7, Iss 3, Pp e06518- (2021)
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder with a prevalence of 1:3000 births and a wide variety of clinical manifestations. Cutaneous neurofibromas (cNF) are among the most common visible manifestations of N
Externí odkaz:
https://doaj.org/article/e95f9d36d332450080eff3f7ff96a63f
Autor:
Alessandra Santos, Mauro Geller, Spyros Mezitis, Allan E Rubenstein, Lisa Oliveira, Daniel JM Medeiros Lima, Mendel Suchmacher Neto, Rafael Nigri, Karin Gonçalves Soares Cunha, Sanyu Takirambudde, Marcia Gonçalves Ribeiro
Publikováno v:
Clinical Pathology, Vol 13 (2020)
Introduction: Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant genetic disorders. Some clinical manifestations are present at birth, while some develop during childhood, and others can occur at any age. Given the early age
Externí odkaz:
https://doaj.org/article/5ee9f8927324419a9a417b2b782e36f8
Autor:
Rafaela E. Rozza-de-Menezes, Nicolle C. Gaglionone, Raquel M. Andrade-Losso, Orlando H. K. Siqueira, Lilian M. Almeida, Kamila da S. Peruzini, Marco A. C. Guimarães-Filho, Carolina I. Brum, Mauro Geller, Karin S. Cunha
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-5 (2017)
Abstract Background Multiple cutaneous neurofibromas are a hallmark of neurofibromatosis 1 (NF1). They begin to appear during puberty and increase in number and volume during pregnancy, suggesting a hormonal influence. Ghrelin is a hormone that acts
Externí odkaz:
https://doaj.org/article/54a8fbaca24f4deba55af0fb4880a31a
Publikováno v:
Case Reports in Ophthalmology, Vol 8, Iss 2, Pp 358-361 (2017)
We describe the case of a neurofibroma on the lacrimal caruncle of a female patient with neurofibromatosis type 1 (NF1). NF1 is an autosomal dominant genetic disease with a wide variety of clinical manifestations, one of the most common of which is n
Externí odkaz:
https://doaj.org/article/a758507fc8bf462daba0d7b02cd4e1ef
Autor:
Marcio Steinbruch, Carlos Nunes, Romualdo Gama, Renato Kaufman, Gustavo Gama, Mendel Suchmacher Neto, Rafael Nigri, Natasha Cytrynbaum, Lisa Brauer Oliveira, Isabelle Bertaina, François Verrière, Mauro Geller
Publikováno v:
International Journal of Vascular Medicine, Vol 2020 (2020)
Background. Phlebotonics have beneficial effects on some symptoms related to chronic venous disease (CVD) of the lower limbs. The most commonly used one is diosmin, available in a pure semisynthetic form or as a micronized purified flavonoid fraction
Externí odkaz:
https://doaj.org/article/8c9cb88a0d4c4cdc996314c755e4a682
Autor:
Carlos Pereira Nunes, MD, Claudio de Campos Rodrigues, MD, Carlos Alfredo Franco Cardoso, MD, Natasha Cytrynbaum, MD, Renato Kaufman, MD, PhD, Helio Rzetelna, MD, Gerson Goldwasser, MD, Alessandra Santos, MD, Lisa Oliveira, MS, Mauro Geller, MD, PhD
Publikováno v:
Current Therapeutic Research, Vol 92, Iss , Pp 100591- (2020)
ABSTRACT: Background: Motion sickness can be triggered in a variety of situations and is characterized primarily by nausea and vomiting. Ginger is widely used in treating conditions including chemotherapy-associated gastrointestinal symptoms, morning
Externí odkaz:
https://doaj.org/article/bb9c665e4f08469199a32faab30ee481